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Effects of Metals in in Vitro Bioassays
by Michael A. Sirover*
The capacity ofin vitrobioassays todetect the potential carcinogenicity ofmetal compounds is
reviewed. The in vitro bioassays discussed include: bacterial reversion analysis to determine the
capacity of metal salts to revert SalmoneUa typhimurium histidine auxotrophs or to revert
Escherichia coli WP 2 tryp- to tryptophan prototrophy; examination ofthe ability ofmetal salts
to preferentially inhibit cell growth in Bacillus subtilis cells deficient in DNA repair pathways;
determination of the ability of metal salts to induce resistance to base analogs in mammalian
cells; the capacity of metal salts to enhance viral transformation of mammalian cells or to
transform cells in the absence of virus; and the ability of metal salts to induce chromosomal
aberrations in mammalian cells. Usingeach ofthese in vitrobioassays, diverse metal compounds
have been identified as potential carcinogens. Furthermore, the use ofdifferent compounds ofa
specific metal may allow a determination ofthe valence which may be required for carcinogenesis.
Introduction
Repeated observations have suggested that en-
vironmental agents are causative factors in the
development ofhuman neoplasia (1-5). As epidemi-
ological studies as well as animal experimentation
can be performed on only a few compounds at great
expense and over extended intervals, recent atten-
tion has focused on the development of short-term
in vitro bioassays through which suspected carcin-
ogens may be detected (6-10). The most widely
used bioassay is that developed by Ames which
uses reversion to histidine prototrophy in S.
typhimurium as a means to detect potential human
mutagens and carcinogens (11, 12). This bioassay,
as well as most others which have been developed,
ultimately quantitate the capacity ofenvironmental
agents to induce an alteration in the nucleotide
sequences which comprise the genetic information
in the cells DNA.
Metals have been shown to be carcinogenic in
laboratory animals (13-15) and have been implicated
as human carcinogens (16, 17). In this review the
main in vitro bioassays which have been used to
screen alarge number ofmetal compounds fortheir
mutagenicity and fortheir potential carcinogenicity
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will be discussed. In particular, this review will
examine the capacity ofmetal compounds to induce
mutations in procaryotes and in eucaryotes; to
enhance the viral transformation of mammalian
cells inculture; to induce transformation ofhamster
embryo cells invitro; and to induce sister-chromatid
exchanges and other chromosomal aberrations in
eucaryotic and in human cells. The other main
bioassay used to detect potential metal mutagens
and carcinogens, the infidelity ofDNA synthesis in
vitro (18-20), is discussed in a companion paper.
In this review I shall alsoconsiderthehypothesis
that short-term in vitro bioassays may be used to
determine which compounds of specific metal car-
cinogens pose the greatest risk with regard to the
induction of human neoplasia.
Bacterial Mutagenesis as an
in Vitro Bioassay for
Metal Compounds
The observation that many chemical carcinogens
are also mutagens has led to the development of
several bacterial systems as in vitro bioassays. The
basis of these assays in the quantitation of the
capacity of environmental agents to revert pre-
viously induced mutations or to inhibit their capac-
ity for cell growth. A brief description of these
assays will be provided for the purpose of this
163review. A more extensive review ofeach assay can
be consulted for more detailed analysis of the
systems per se or for a further consideration of
metal mutagenesis (12, 21, 22).
Foremost among in vitro bioassays is that devel-
oped by Ames in which the reverse mutation of
histidine requiring strains of S. typhimurium to
histidine prototrophy is quantitated. The tester
strains used contain additional defects to facilitate
mutagenesis. Inthe initial experiments definingthe
Salmonella assay approximately 250 chemicals were
examined (23, 24). Ofthe 175 chemical carcinogens
tested, 157 or 90% were mutagenic. In contrast, of
the 108 non-carcinogenic chemicals tested, 94 or
87% did not produce detectable his+ revertants
above background levels. Subsequent analysis using
this assay has been extended to a wide variety of
individual chemicals as well as to complex mixtures
of environmental agents (11).
The second bacterial system which has been used
to screen metal compounds measures reverse mu-
tations in E. coli strain WP 2 tryp- (22). Analogous
to the Salmonella assay this system quantitates the
capacity ofexogenous agents to revert the bacteria
to tryptophan prototrophy. As DNA is considered
the critical target for chemical carcinogens, the E.
coli WP 2 strains employed are usually deficient in
specific DNA repair pathways. This deficiency
enhances the potential for detecting environmental
mutagens as DNA lesions will tend to persist for
greater intervals due to the cells inability to excise
the DNA adducts.
The third bacterial system utilized as an in vitro
bioassay for metal compounds measures the capac-
ity of exogenous agents to inhibit cell growth (25).
Recombination proficient (rec+) and recombination
deficient (rec-) strains are used. The hypothesis
which forms the basis of this bioassay is that the
agent tested will inhibit cell growth to a greater
degree in the rec strains which is deficient in DNA
repair. One presumes that the persistent lesions in
DNA will prevent the expression of specific genes
whose products are essential to cell growth or that
the DNA lesions will prevent DNA replication and
thus inhibit cell growth. Thus, in parallel cultures,
one can measure an inhibition zone of cell growth
for rec+ cells as well as for rec- cells. The expecta-
tion is that the greater the difference in inhibition
zones, the greaterthe potentialmutagenicity ofthe
compound tested.
Effects of Metals in Bacterial
Bioassays
Chromium has been implicated as a human car-
cinogeninducingthe formation oflungtumors after
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industrial exposure (15). Venitt and Levy (26) in
1974 reported that chromates were mutagenic in
the E. coli B WP 2 system. Using hexavalent
chromium compounds they observed a 3- to 4-fold
increase in the number of revertants per plate as
compared to untreated controls. Similarly, Nishioka
(27)usingtherecassaydemonstrated thathexavalent
chromium compounds strongly inhibited cell growth
and thus had a demonstrative rec effect. In parallel
studies, he also showed that potassium dichromate
wasmutagenicinE. coli B WP2 tryp-uvrA-which
is deficient in nucleotide excision repair (28).
In spite of the usefulness of the Ames assay in
analyzing diverse types ofchemicals, initial studies
using this in vitro assay failed to detect the
mutagenicity of several metal carcinogens (23, 24).
This might have reflected technical problems which
related to the chelation of free metal cations by
components of the bacterial medium. However,
later studies by several groups, including that of
Ames, have been successful in determining metal
mutagenesis using this in vitro assay. Lofroth and
Ames (29) reported that chromate and dichromate
induced frameshift mutations in three different
strains of S. typhimurium. Further studies by
Petrilli and de Flora (30) confirmed that hexavalent
chromium compounds (sodium dichromate, chromic
acid and calcium chromate) produced significant
increases in histidine reversion using four tester
strains. The nature of the reverse mutations re-
quired to regain histidine prototrophy suggested
that the chromium compounds produced both
frameshift and base pair mutations. Furthermore,
the mutagenic activity ofhexavalent chromium was
independent ofmicrosomal metabolism. Using lead
chromate, Nestman et al. (31) reported increased
mutagenicity in both the Ames Salmonella assay
and the E. coli WP 2 tryp-fluctuation test. As both
chromium and lead are potential human carcino-
gens, it was ofinterest to observethatthe substitu-
tion oflead chlorideforlead chromate resulted in an
elimination of the mutagenic effect of the metal
compound.
In contrast to the mutagenic capacity ofhexavalent
chromium, parallel studies demonstrated that tri-
valent chromium was inactivated as a mutagen (29,
30). With the use of two trivalent chromium com-
pounds (chromium potassium sulfate and chromic
chloride), no increase in the reversion frequency
was observed in the presence or absence of a
microsomal fraction from rat liver or from human
erythrocytes. Although hexavalent chromium could
be deactivated by enzymaticmetabolism (32), triva-
lent chromium could not be converted to the
hexavalent form. Of interest was the observation
that microsomes from rat lung had no effect on the
Environmental Health Perspectiveesmutagenicity of hexavalent chromium. These re-
sults may be of importance as chromium may
localize and accumulate in human lung during
occupational or environmental exposure. Thus the
inability of human lung to deactivate hexavalent
chromium compounds may play a role in chromium
carcinogenesis in humans. However, trivalent chro-
mium could be chemically oxidized in vitro by using
potassium permangenate (23). Similarly, Nishioka
had reported that the rec effect of potassium
dichromate was lost after treatment with Na2SO3,
which is the reducing agent (27). Thus, it would
appear that although chromium per se is a metal
carcinogen, the valence state ofthe metal within a
specific compound may be of prime importance
(Table 1). Further study is required to determine
whether trivalent chromium compounds can be
considered relatively innocuous with regard to
carcinogenicity and whether the focus should re-
main on hexavalent compounds.
Arsenic compounds have been examined in each
of these three bacterial in vitro assays (Table 1).
Trivalent arsenic (arsenite) and pentavalent arsenic
(arsenate) were inactive in the Ames assay (29). In
contrast, Nishioka reported that rec effects were
observed with both trivalent (AsC13 or NaAsO2)
and pentavalent (Na2HAsO4) arsenic (27). The
result with AsCl3 in the rec assay is the initial
report that a free metal cation (As3+) was a poten-
tial mutagen. Furthermore, trivalent arsenic as
sodium arsenite induced tryp + reversions inE. coli
WP2. However, recent results suggest that arse-
nite may not induce mutations in E. coli WP2 cells
(T. Rossman, M. Molina, D. Stone, and W. Troll,
Mutat. Res. Submitted). It was suggested that the
results observed by Nishioka might have been due
to the intrinsic variability ofbackground mutation
frequencies. As arsenic is implicated as a human
carcinogen, the absence of arsenic induced muta-
tion would predicate another mechanism. One in-
triguing possibility is that arsenic may inhibit the
enzymes which comprise the excision repair path-
ways (28, 34).
Selenium has been investigated in both the rec
assay and in the Ames Salmonella test. Using the
rec assay, Nakamuro et al. (23) tested five selenium
compounds (35). They reported that selenate failed
to produce any difference in inhibition zones. How-
ever, selenite did show a small but significant rec
effect. In contrast, Lofroth and Amesreported that
usingthe Salmonella test system, selenite was not a
mutagen (<< 0.01 revertants/mole) but that sele-
nate produced a small number of mutations (0.03
revertants/mole) (29). Recently, Noda et al.
reexamined this question (36). They reported that
selenate and selenite were weak mutagens in both
the rec assay and in the Salmonella test. In their
experiments which did not utilize a microsomal
activating system, selenite induced 0.2 revertants/
mole while selenate induced 0.05 revertants/mol in
the Ames assay. The basis for these conflicting
results is unknown but may spring from the mar-
ginal effects of selenium as a bacterial mutagen.
The role of platinum compounds as cancer
chemotherapeutic agents has resulted in several
investigations on the capacity of these compounds
to act as bacterial mutagens (37-40). In particular,
the stereospecificity implicit in the usefulness of
cis-platinum (II) diamminedichloride (cis-PDD) as
compared to its transisomer in chemotherapy has
also been examined in in vitro bioassays. Beck and
Brubaker initially reported that cis-PDD was
Table 1. Metal mutagenesis in bacterial in vitro bioassays.a
Reversion of Reversion of Rec effect in
S. typhimur?iun E. coli WP 2 B. siubtilis
his-, revertants/ tryp-, colonies/ (difference in
Metal Valence or charge nmole plate inhibition zone) Reference
Arsenic 3 0.01 N.D. + (27, 29)
5 0.01 37.7 (8.0) +
Chromium 3 172 (194)b N.D. - (27, 32, 33)
6 925 (238)b 41.7 (8.0) +
Platinum -2 2 N.D. N.D. (42)
0 100 N.D. N.D.
+2 0.2 N.D. ND.
Selenium 4 0.20 N.D. (29, 35, 36)
6 0.05 N.D. +
aDetermination ofthe capacity ofmetal compounds to induce mutations or to preferentially inhibit cell growth aredescribed in the
respective references. The numbers in parentheses refer to the number of mutations observed in simultaneous untreated controls.
Charge refers to the netcharge onthe metal compound while valence defines the state ofa metal within acompound. The convention of
Nishioka has been used as a determination of the rec effect (27).
bIn revertants per plate.
August 1981 165cytotoxicto severalE. colistrains deficient in DNA
repair (41). They concluded that this cytotoxicity
was due to the production ofintrastrand crosslinks
in DNA.
Mutagenicity studies in the Salmonella assay
demonstrated the capacity of cis-PDD to induce
histidine reversions. In a study of 12 platinum
compounds, Le Cointe et al. investigated the
stereospecificity of platinum-induced mutagenesis
(42). They observed that cis-PDD was the most
potent mutagen tested. In the Ames assay cis-PDD
produced 100 reversions/moles as compared to a
reversion frequency ofbetween 0.2-2.0 reversions/
mole observed for the other eleven platinum com-
pounds. Le Cointe et al. also reported that PDD
produces base-pair mutations. Of interest was the
observation that the charge of the platinum com-
pound appeared to directly affect the reversion
frequency (Table 1).
Although chromium, arsenic, selenium, and plat-
inum have been examined in some detail, rigorous
analysis of other metals using all three in vitro
bioassays remains undetermined. Manganese in-
duced mutations in bacteriophage T4 (43) and in
yeast (44). Copper caused mutations in E. coli (45)
and in B. subtilis (46). Nishioka has screened a
large number ofmetal salts in the rec assay (27). In
addition to the metals previously discussed, rec
effects were observed for cadmium, mercury, man-
ganese, and for molybdenum. However, silver,
beryllium, cobalt, copper, iron, nickel, lead, and
zinc were negative in this assay. However, a
systematic analysis of metal mutagenesis has not
yet been performed using either the Ames Salmo-
nella assay or the E. coli WP 2 tryp- in vitro
bioassays.
Metal Mutagenesis in
Mammalian Cells
The decreased sensitivity of mammalian cells to
base analogues has been used to detect metal
compounds as mutagens in mammalian cells (47,
48). In particular, mutants in the HGPRT locus can
be identified by the acquired capacity to grow in
media containing thioguanine or 8-azaguanine. The
HGPRT locus specifies a purine salvage enzyme,
the hypoxanthine-guanine phosphoribosyl transfer-
ase. A deficiency in this enzyme renders the cell
insensitive to the base analogues. Thus, in contrast
to bacterial systems which quantitate the reversion
of a previously induced mutation, this system
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measures the induction of the initial mutation. In
general, hamster cells have been used as model
systems to approximate the effects ofmetals on the
HGPRT locus in mammalian cells.
O'Neill et al. reported that platinum as cis-
dichlorodiammine platinum (II) induced thioguanine
resistance in Chinese hamster ovary cells (49).
Using 3 ,M cis-PDD they observed an increase of
approximately 30-fold in induced mutation as com-
pared to spontaneous mutations in parallel cul-
tures. Similar results were reported by Turnbull et
al. usingV79 Chinese hamster cells (50). A compar-
ison ofsix platinum compounds by Taylor et al. (51)
demonstrated thatavarietyofplatinumcompounds
induced 8-azaguanine resistance in CHO cells. In
this study, both cis-PDD and Pt(SO4)2 were equally
effective in inducingmutations. In contrast, similar
treatment with varying concentrations of K2PtCl4
or K2PtCl6 did not induce any alteration in sensitiv-
ity to 8-azaguanine. However, repeated subculture
of CHO cells in 10 ,uM K2PtCl6 resulted in a 2- to
3-fold increase in the induction of 8-azaguanine-
resistant colonies. This induction required expo-
sure ofthe cells for 10populationdoublings and was
maintained after 20 population doublings. Further
analysis by Zwelling et al. in V79 Chinese hamster
lung cells demonstrated that cis-PDD was more
mutagenic than trans-PDD at equitoxic doses (52).
This confirms the previous results observed using
bacterial in vitro assays. Furthermore, Zwelling et
al. reported that the number of interstrand cross-
links produced by both compounds were identical.
These results would indicate that other lesion(s)
were the causative DNA lesions for mutagenesis.
Chromium has alsobeen examined inthe Chinese
hamsterV79 systemfortheinduction of8-azaguanine
resistance. In agreement with those results ob-
tained in bacterial assays, Newbold et al. observed
thathexavalentchromiumcompoundsinducedmuta-
tions while trivalent chromium compounds were
inactive (53). Three hexavalent compounds were
used, each of differing solubility in water; potas-
sium dichromate which is highlywater-soluble, zinc
chromate which is slightly water-soluble, and lead
chromate which has a very low solubility. Both
potassium dichromate and zinc chromate induced
significant numbers of colonies resistant to
8-azaguanine. In contrast, lead chromate was inac-
tive yielding results comparable to those observed
with trivalent chromium compounds. These results
are ofinterest in that lead chromate was mutagenic
in the Ames assay. The reason for this discrepancy
remains unknown. Other metals have been ana-
lyzed in mammalian mutagenesis assays (54). These
results should be available in the near future (J. P.
O'Neill, personal communication).
Environmental Health PerspectivesEnhancement of Viral Induced
Transformation by Metal
Compounds
Exposure of hamster embryo cells to the simian
adenovirus SA7 results in viral transformation of
the cells (55). Subsequent analysis after transfor-
mation demonstrated that the viral genome was
integrated into the hamster DNA as defined by
nucleic acid hybridization studies. In a series of
publications, Casto and DiPaolo reported that treat-
ment ofthe cells with diverse chemical carcinogens
resulted in an enhancement of the frequency of
viral induced transformation (56, 57). In particular,
treatment with polycyclic aromatic hydrocarbons
or with alkylating agents significantly enhanced
viral transformation as compared to that observed
with the virus alone. They hypothesized that this
increase resulted from additional sites in DNA
which were now accessible to the virus for integra-
tion. The production of these extra sites were due
presumably to DNA alterations induced by
carcinogen-DNA interactions.
Using this system as an in vitro bioassay, they
then examined whether specific metal compounds
could similarly enhance viral transformation (58).
Inthese experiments theyinvestigated 25metals in
a total of38 metal salts. Ofthe 38 metal salts which
were examined, 24 significantly enhanced viral
transformation. These metal compounds were di-
vided into three categories according to the metal
concentration required for enhancement. The first
group which showed highest activity at the lowest
concentrations included antimony, arsenic, cadmi-
um, chromiun and platinum. The second group
contained beryllium, cobalt, copper, lead, manga-
nese, mercury, nickel, silver, thallium, and zinc.
The third group contained only iron. There was a
direct relationship between the capacity of metal
salts to enhance viral transformation and their
reported mutagenicity or carcinogenicity. Of the
metals tested, only the results with zinc were
inconclusive. A partial summary of the data is
presented in Table 2.
It is interesting to note that treatment of the
cells with soluble metal salts resulted in increases
in viral transformation. This is in contrast to the
results observed using bacterial assays in which
most metal cations did not induce mutations. Of
interest also is the agreement ofthe results in this
bioassay as compared to the results obtained using
the fidelity of DNA synthesis in vitro as a test
system (18-20). Those metals which enhanced viral
transforrnation altered the accuracy of DNA syn-
thesis; metals which did not increase transforma-
tion did not affect fidelity. The only exception was
iron which enhanced transformation but did not
alter fidelity.
Transformation of Syrian Hamster
Cells by Metal Compounds
Recent studies by DiPaolo and Casto have dem-
onstratedthatmorphologicaltransformationofSyrian
hamster cells could itself by used as an in vitro
bioassay to detect potentially carcinogenic metal
compounds (59). In these experiments, cells were
exposed to varyingconcentrations ofmetal salts for
one day. After 7-8 days of culture, the cells were
analyzedfortransformation. Thecells wereclassified
Table 2. Effect of metals on the transformation of mammalian cells.a
Enhancement of viral transformation Transformation of Chinese hamster cells
(enhancement ratio; concentration) (transformed colonies/total colonies),
Metal Valence mMb %c
Arsenic 3 2.4 ( 0.1) 4.13 (5)
Beryllium 2 2.6 ( 0.56) 6.40 (5)
Cadmium 2 2.2 ( 0.001) 4.02 (1)
Chromium 6 2.4 ( 0.01) 3.48 (1)
Nickel 2 3.4 ( 0.38) 5.45 (10)
Barium 2 0.9 ( 4.8)
Calcium 2 0.8 ( 6.8)
Lithium 1 0.5 (23.6)
Strontium 2 0.9 ( 3.8)
Titanium 4 0.8 (12.5)
'The capacity of metals to enhance viral transformation or to transform mammalian cells in the absence of exogenous virus was
determined as described (59, 60). The enhancement ratio was determined by calculating the ratio oftransformed foci observed in the
presence of metals to that observed in untreated cells.
bThe numbers in parentheses refer to the lowest concentration required to observe enhancement or the highest concentration used
for compounds scored as negative.
'The numbers in parentheses refer to the concentration (,ug/ml) required to observe that percentage of transfornation.
August 1981 167as transformed ifthe colony formation was altered
due to uncontrolled cell growth and due toirregular
cell arrangement.
In this system 12 metals were examined (Table
2). Six metal compounds induced morphological
transformation. Positive results were achieved with
nickel sulfate, cadmium acetate, sodium chromate,
nickel subsulfide, beryllium sulfate, and sodium
arsenate. In each instance increasing concentra-
tions ofthe metal salt resulted in an increase in the
number oftransformed colonies observed. No trans-
formation was observed in untreated cultures.
Furthermore, each metal in the compounds used
has been implicated as a carcinogen in animals or in
humans.
In contrast to the positive results observed with
those metal salts, no transformation was observed
using ferric oxide, titanium dioxide, sodium tung-
state, zinc chloride, aluminum chloride, or with
amorphous nickel sulfide. Ofthese metals tested in
vivo, the determination of the carcinogenicity of
iron and ofzinc have been inconclusive. Iron in the
form ofiron-dextran and intratesticular injection of
zinc have produced tumors (60, 61). However,
administration of the metals by all other routes
tested or in other forms has not resulted in tumor
formation. Thus the negative results obtained in
this bioassay as well as other results obtained in
other in vitro tests could serve potentially as
supportive data for a determination of the hazards
of iron and of zinc compounds.
Induction of Chromosomal
Aberrations by Metal
Compounds
The capacity of exogeneous agents to perturb
normal chromosome structure has been used quite
successfullly as aninvitro bioassay (62-65). Cytogenic
analysis provides a rapid and reproducible test to
determine whether exposure to specific chemicals
results in the production of diverse chromosomal
lesions. This type of analysis also permits the
simultaneous determination of various types of
chromosomal perturbations. The facilitation by
exogeneous agents of genetic disturbances at the
chromosomal level would presumably be due to
DNA damage. In particular, strand breaks or the
induction of DNA crosslinks would provide attrac-
tive sites forthe transfer ofnucleotide sequences to
sites on other chromosomes.
The in vitro determination ofchromosomal aber-
rations produced in vivo in cells from individuals
exposed to specific chemicals may provide the most
relevant bioassay to monitor environmental haz-
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ards. In particular, human lymphocytes provide a
readily accessible source with which to assay large
populations of exposed individuals. Using popula-
tions of industrial workers, recent studies on the
capacity ofmetals to produce chromosomal aberra-
tions have been equivocal. Bauchinger et al. deter-
mined the extent of chromosomal perturbations in
lymphyocytes from workers in a zinc smelter plant
(66). These individuals had increased blood levels of
lead and of cadmium. These workers had a 2- to
3-fold increase in the number of aberrations/cell
with respect to comparable controls. Furthermore,
the increase in aberrations was not selective but
insteadreflected an overallincrease foreachtype of
perturbation. However, other studies by Evans
and O'Riordan (67) and by O'Riordan et al. (68)
failed to observe any increase in chromosomal
aberrations inindustrialworkers exposed tolead or
to cadmium.
Analysis ofthe capacity ofchromium compounds
to induce chromosomal aberrations substantiates
the importance of hexavalent chromium in metal
carcinogenesis. Usinghamster embryo cells, Tsuda
and Kato reported thatincreasingconcentrations of
potassium chromate induced increasing numbers of
chromosomegaps, chromatidorchromosomebreaks,
or chromosome exchanges (69). However, prior
treatment of potassium dichromate with Na2SO3
eliminated the induction of chromosomal aberra-
tions. This is in agreement with previous results in
bacterial systems demonstrating that metabolism
of hexavalent chromium eliminated chromium in-
duced mutagenesis.
Similar studies in other mammalian cells demon-
strated the capacity of hexavalent chromium to
induce chromosomal perturbations. In human lym-
phocytes, Nakamuro et al. examined the chromo-
some breaking capacity of hexavalent chromium
(70). At low levels ofexposure, the yield ofaberra-
tions was linear with dose. In Chinese hamster
ovary cells, hexavalent chromium induced a 10 fold
increase in the number of chromosomal perturba-
tions as compared to the untreated control (71).
With sodium dichromate, the number ofchromatid
breaks orgaps was dose-dependent. In mousecells,
both K2Cr2O7 and CrO3 induced large numbers of
aberrations (72). Sister chromatid exchanges were
observed in human fibroblasts exposed to either
K2CrO4 or to K2Cr2O7 (73).
In contrast to the results observed withhexavalent
chromium, exposure of mammalian cells to triva-
lent chromium did not result in the production of
similar numbers ofchromosomal perturbation (70).
Although these results support those observed in
bacterial assays, trivalent chromium did affect
chromosomal structure in some studies. In human
Environmental Health Perspectivesleukocytes, hexavalent chromium compounds were
significantly more effective in inducing chromo-
somal rearrangements than were trivalent chro-
mium compounds. However, all of the compounds
tested were comparably effective inducing chroma-
tid gaps. The significant differences were observed
in the number ofchromosome breaks or exchanges.
These results would suggest that the latter type of
perturbation is of more importance with regard to
potential chromium carcinogenesis.
Exposure to cadmium salts has resulted in the
induction of chromosomal aberrations. Using Chi-
nese hamster cells, Rohr and Bauchinger reported
that exposure to 1O0MCdSO4resulted in asignificant
production of chromosomal perturbations (74). De-
termination of the mitotic index suggested a pro-
nounced effect ofcadmium. As unsynchronized cells
were used in this experiment, it was not possible to
ascertain whether a specific part of the cell cycle
was affected or whether cadmium exhibited a
nonspecific inhibitory effect. Using a system com-
parable to that of Casto and DiPaolo, Zasukhina et
al. (75) examined the ability of CdCl2 to affect the
induction of chromosomal aberrations caused by
Kilham virus. Using primary rat embryo cells, they
reported that CdC12 by itself failed to produce any
detectable number ofaberrations above background
levels. In contrast, administration of CdCl2 to
virus-containing cultures increased by 2-fold the
number of perturbations which were observed.
These two studies are of interest in that they
demonstrated the effect offree metal cations on the
induction of chromosomal aberrations. In contrast
to many bacterial studies reporting the lack of
activity of free metal cations, this study suggests
that the interaction of free metal cations with
chromosomal structures may result in specific per-
turbations.
Several systems have been used to determine
that platinum as cis-dichlorodiammine platinum (II)
induced chromosomal aberrations. In human lym-
phocytes, Wiencke et al. (76) demonstrated that
exposure to increasing concentrations of cis-PDD
resulted in a proportional increase in the number of
sister chromatid exchanges (SCE). At a cis-PDD
concentration of 1.0 ,ug/ml, they reported an ap-
proximately 5-fold increase in the number of SCE.
As a function of sequential cell division, there was
aninverse relationship betweenthe numberofSCE
and the number of cell divisions after exposure.
Further analysis in Chinese hamster cells demon-
strated that caffeine produced a synergistic effect
on the induction of chromosomal aberrations by
cis-PDD (77).
Conclusion
In this review I have attempted to briefly sum-
marize recent studies using the major in vitro
bioassays to evaluate the potential carcinogenicity
of metal compounds. In particular, most investiga-
tions have focused on those metals for which
carcinogenicity data are available. As shown in
Table 3, some ofthese metals have been analyzed in
several of the bioassays. However, as is evident
from this compilation, wide gaps remain with
Table 3. Effect of metals in in vitro bioassays.a
Carcinogenicity Bacterial Mammalian Enhancement of Transformation of Chromosomal
Metal in vivo mutagenesis mutagenesis viral transformation mammalian cells aberrations
Arsenic + -? N.D. + + N.D.
Beryllium + N.D. N.D. + + N.D.
Cadmium + -? N.D. + + +
Chromium + -(3) -(3) N.D.(3) N.D.(3) -?(3)
+(6) +(6) +(6) +(6) +(6)
Cobalt ? N.D. N.D. + N.D. N.D.
Copper ? + N.D. + N.D. N.D.
Iron ? ? N.D. + N.D.
Lead + -? N.D. + N.D. N.D.
Manganese ? + N.D. + N.D. N.D.
Mercury ? -(1) N.D.(1) N.D.(1) N.D. N.D.
+(2) N.D.(2) +(2) N.D. N.D.
Nickel + N.D. N.D. + + N.D.
Platinum ? +(2) +(2) +(2) N.D. +(2)
Selenium ? + N.D. N.D. N.D. N.D.
Zinc ? - N.D. + - N.D.
aThe determinations ofthe interactions ofmetal compounds with in vitro bioassays are taken from the text and fromthe appropriate
references. Determinations ofcarcinogenicity are taken from the references (13-17). The designation of -? refers to compounds tested
in only one ofthe available assays. The number in parenthesis refers to the valence or charge ofthe metal. The asterisk (*) refers to
results obtained in systems other than the major in vitro bioassays.
August 1981 169respect to our knowledge ofthe effects ofmany of
these metals.
The greatest use of in vitro bioassays with
respect to metals may be to determine which forms
of a specific metal may pose the greatest risk. It
may be argued that in vivo data have indicated
which metals are potential human carcinogens.
However, it may also be a reasonable expectation
that not all forms ofa given metal pose this hazard.
The valence of the particular metal within the
compound, the net charge on the metal compound,
the orientation ofthe metal within the compound as
well as the solubility of the metal salt may be
determining factors. Thus, several investigations
performed withchromium compounds suggestthat,
although invivo datademonstrate thecarcinogenicity
of chromium in animals or in man, in vitro experi-
ments would indicate that exposure to hexavalent
chromium which crosses cell membranes is biologi-
cally more active than comparable exposure to
trivalent chromium which does not cross cell mem-
branes. Unfortunately, similar studies have not
been performed with most of the other metals
listed. Furthermore, most metals have not been
systematically analyzed with respect totheircapac-
ityto act asbacterialmutagens orfortheircapacity
to induce chromosomal aberrations in mammalian
cells.
Although many metals have been tested for in
vivo carcinogenicity, other metals have not been
adequately tested. Thus, in vitro bioassays may
also serve to identify other metals which are
potential human carcinogens. In vitro bioassays
maythus function to screen alarge number ofmetal
compounds as a first step to focus attention on
specific metal salts. These salts may then be
examinedinvivo. Forexamplecis-dichlorodiammine
platinum (II) induces bacterial mutations as well as
inducing chromosomal aberrations. It is ofinterest
thatthis andrelated compounds produced sarcomas
after s.c. injections in rats, and that it was an
initiator for mouse skin after IP injections (78). In
this respect, it behaves like most cancer chemo-
therapeutic agents which are carcinogenic. Howev-
er, ifinvitro bioassays are used as a "first tier" test
for metal compounds, the unique solubility prob-
lems of metal salts and their potential interactions
with media components have to be considered with
regard to negative results.
Recent evidence suggests that diverse metals
may act synergistically to potentiate the effects of
other mutagens or carcinogens. Stich et al. re-
ported that the mutagenicity ofascorbic acid in the
Ames Salmonella assay was increased 80-foldbythe
addition of copper (79). Similarly, copper, cobalt,
manganese, iron and zinc increased the mutagenic
effect of cis-5,6-dihydro-6-hydroperoxy-5-hydroxy-
thymine on transforming DNA of H. influenzae
(80). Further studies demonstrated that copper
could increase the induction of sister chromatid
exchanges in Chinese hamster cells caused by
exposure to ascorbic acid orto sodium bisulfite (81).
Furthermore, manganese, copper, or iron enhanced
unscheduled DNAsynthesis induced byisoniazid or
other hydrazines (82). Thus, the synergistic effects
oftransition metals suggest the possibility that in
vitro bioassays may serve as useful tools to further
investigate the capacity of metals to enhance the
mutagenicity or carcinogenicity of other agents.
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